Omeros | OMER - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Adma Biologics USD 3.52B 824M 2026-03
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Cytokinetics USD 7.77B 1.19B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
Heron Therapeutics USD 133M 105M 2026-03
Insmed USD 37.12B 6.68B 2025-12
Knight Therapeutics CAD 625.23M 24.71M 2026-03
MacroGenics USD 192M 90M 2026-03
Pacira USD 1.06B 94M 2025-12
Pfizer USD 153.96B 12.4B 2026-03
Sarepta Therapeutics USD 2.26B 238M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12